We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Angle Plc | LSE:AGL | London | Ordinary Share | GB0034330679 | ORD 10P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 8.00 | 7.50 | 8.50 | 8.00 | 8.00 | 8.00 | 1,015,704 | 08:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Business Services, Nec | 2.19M | -20.13M | -0.0624 | -1.28 | 25.81M |
Date | Subject | Author | Discuss |
---|---|---|---|
09/10/2024 19:01 | CTCs only of use in research not clinical trials was the message I came away with. | toffeeman | |
09/10/2024 16:11 | Lots of rollovers today to fool mislead any novice that there strong buying or weak selling when it's around mid price to sell currently online | dave4545 | |
09/10/2024 14:52 | How ctDNA Can Unveil Early Signs of Molecular Response in Drug Development Wednesday, October 09, 2024 18.00 hxxps://event.on24.c | toffeeman | |
09/10/2024 13:07 | Castor you referring to Bliss Bio and their partnering with Eisai? Agl's parsortix was adopted for patient selection? I remember in the Jan rns they referred to BB1701 "ANGLE plc...is delighted to announce that it has signed a contract with the global pharmaceutical company, Eisai Inc...Under the agreement, in a pilot study worth US $250,000 to ANGLE, ANGLE will provide CTC analysis with its Portrait HER2 assay to assess breast cancer patients' HER2 (human epidermal growth factor receptor 2) status in a Phase II study of the HER2 targeting antibody-drug conjugate (ADC) BB-1701. Success in the pilot study offers the potential for multiple large scale follow-up studies....ANGLE's Portrait HER2 assay enables quantitative assessment of both HER2 protein expression (via IF) and HER2/neu gene amplification (via FISH) to identify patients who could benefit from anti-HER2 ADC treatment." | boris cobaka | |
09/10/2024 12:40 | Looking online the spread is quite good. It's around 0.35p inside both ways so 7.85-8.15p approx the spread The mm's seem to be happy with all this 2 way trade each day, no need to move the price and they are making a daily crust while concentrating on other fast moving stocks. Agl will have it's day or spike but it's a case of when and from what level. | dave4545 | |
09/10/2024 12:22 | Paulx she confirmed it earlier. Are you only on lse? At Least 300k taken on the strength but I'm not sure. Ignorance is Bliss I guess. | castor111 | |
09/10/2024 09:49 | Thanks for that...although I was thinking more of a couple of big fat cheques to get the ball rolling as it were....:-)) | sawney | |
09/10/2024 09:33 | sawney ...........that link is to Angle presenting their DDR assay which was commissioned and paid for by Artios Pharma and led to contract with AstraZeneca. | bermudashorts | |
09/10/2024 09:18 | Victor Meldrew Vs Adrian Mole are fighting it out on an anonymous bulletin board.Are you not entertained? | atmysignal | |
09/10/2024 09:14 | Thanks Sawney.Let's leave adwbones to their multiple aliases. Childish.Great prospects here. | muffster | |
09/10/2024 09:09 | ...and another...pity big pharma has still not got the cheque book out... | sawney | |
09/10/2024 08:38 | You’re not anywhere near as clever as you think. It’s why you can’t address what I’m actually saying, instead once again bragging how you made money. You had a go at me on 29th May for saying I thought a placing was coming and by 7th June when it came you claimed you’d sold down because you knew it was. Nowhere have I said I think these boards affect the price. I’ve said you do. You’ve been caught out but yes let’s leave it there and you filter me pal - better than when you were sending me private messages when you agreed with my analysis, whereas when I called you out you suddenly hate me. I’ll be keeping my eye on you and your narcissistic rat like behaviour though. | adw198 | |
09/10/2024 08:03 | Nah, Adw is Victor Meldrew | atmysignal | |
08/10/2024 22:34 | 698 and adw....same person I reckons. | muffster | |
08/10/2024 17:18 | I watch the blood for signals bright,Not tissue's tale, but fluid's light.I track the HER2, high or low,A patient's path, I aim to show.Pharma eyes are on my test,For outcomes better than the rest.What am I, with change in sight,Disrupting norms in silent flight?:) | 5oletrader | |
08/10/2024 08:25 | Calm down dear!Bones is an anonymous poster on a bulletin board | atmysignal | |
08/10/2024 02:29 | Oh dear that clearly touched a nerve and yes I have read your posts on this and many other boards. But at least you are now being more open and honest which is ok. Please don't worry too much about my losses on this or any other share, as I have a very wide portfolio and have been investing (note the difference) on a number of shares for a very long time and I am fully aware of the risks of further potential fundraises but I don't disguise the fact that I am not currently invested in AGL please see my post 25097 before the latest raise. ATB | pj84 | |
07/10/2024 22:46 | I am a strong believer in the science and that Angle will eventually see the promise that I, like a lot of shareholders at the time, believed initially would quickly follow from the FDA approval and lead to deals and commercialisation. At that stage I was worried we would get bought out too quickly by the likes of Abbot. We all now know that was wrong. Since then, like a lot of holders I have realised that commercialisation is further ahead than we believed at the time, and I have been sitting on the sidelines waiting for the right time to reinvest. Unlike Bones I like to think my posts are more balanced and my last post 26242 posted a positive update by Berenberg with a price target of 70p but my own comments at the end were “If it's similar to this year the full year results for December 24 will be released in early June 25. At this stage I still have doubts about whether the cash in June 25 will be sufficient to see them through to H2 26 but that may change depending on what happens between now and June 25.” My position hasn’t changed since then. Bones on the other hand has had a complete 180 change of view from there will definitely be a need for another fundraise around the time of the full year 24 results, to I have now bought and don’t see that as a problem anymore (but he no doubt reserves the right to sell at any point between now and then and will again post with certainty that there will be a fundraise!) | pj84 | |
07/10/2024 13:47 | Can triple or more. Look at it's history.Ask Bones LOL | atmysignal | |
07/10/2024 13:44 | And the rest Dave, and the rest. | jelenko |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions